Antiviral Cytokines Induce Hepatic Expression of the Granzyme B Inhibitors, Proteinase Inhibitor 9 and Serine Proteinase Inhibitor 6

Journal of Immunology

Volumn 172, Issue 10, 2004, Pages 6453-6459

  Barrie, Mahmoud B ^a   Stout, Heather W ^a   Abougergi, Marwan S ^a   Miller, Bonnie C ^a   Thiele, Dwain L ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CYTOKINE; ENZYME INHIBITOR; GAMMA INTERFERON; GRANZYME B INHIBITOR; PROTEINASE INHIBITOR 9; RECOMBINANT ALPHA2B INTERFERON; SERINE PROTEINASE INHIBITOR 9; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROTECTION; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOREGULATION; INFECTION RESISTANCE; LIVER CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION;

EID: 2442624463     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.10.6453     Document Type: Article

References (39)

1. Kagi, D., F. Vignaux, B. Ledermann, K. Burki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528.
2. Mullbacher, A., P. Waring, R. Tha Hla, T. Tran, S. Chin, T. Stehle, C. Museteanu, and M. M. Simon. 1999. Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes. Proc. Natl. Acad. Sci. USA 96:13950.
3. Russell, J. H., and T. J. Ley. 2002. Lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol. 20:323.
4. Bortner, C. D., and J. A. Cidlowski. 2002. Cellular mechanisms for the repression of apoptosis. Annu. Rev. Pharmacol. Toxicol. 42:259.
5. Derfuss, T., and E. Meinl. 2002. Herpesviral proteins regulating apoptosis. Curr. Top. Microbiol. Immunol. 269:257.
6. Bird, C. H., V. R. Sutton, J. Sun, C. E. Hirst, A. Novak, S. Kumar, J. A. Trapani, and P. I. Bird. 1998. Selective regulation of apoptosis: the cytotoxic lymphocyte serpin, proteinase inhibitor 9, protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway. Mol. Cell. Biol. 18:6387.
7. Sun, J., C. H. Bird, V. Sutton, L. McDonald, P. B. Coughlin, T. A. De Jong, J. A. Trapani, and P. I. Bird. 1996. A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifier A is present in cytotoxic lymphocytes. J. Biol. Chem. 271:27802.
8. Medema, J. P., D. H. Schuurhuis, D. Rea, J. van Tongeren, J. de Jong, S. A. Bres, S. Laban, R. E. Toes, M. Toebes, T. N. Schumacher, et al. 2001. Expression of the serpin, serine protease inhibitor-6, protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cells. J. Exp. Med. 194:657.
9. Andrade, F., H. G. Bull, N. A. Thornberry, G. W. Ketner, L. A. Casciola-Rosen, and A. Rosen. 2001. Adenovirus LA-100K assembly protein is a granzyme B substrate that potently inhibits granzyme B-mediated cell death. Immunity 14:751.
10. Kafrouni, M. I., G. R. Brown, and D. L. Thiele. 2001. Virally infected hepatocytes are resistant to perforin-dependent CTL effector mechanisms. J. Immunol. 167:1566.
11. Liu, Z. X., S. Govindarajan, S. Okamoto, and G. Dennert. 2000. Fas- and TNFR-1-dependent but not perforin-dependent pathways cause injury in livers infected with an adenovirus construct in mice. Hepatology 31:665.
12. Kafrouni, M. I., G. R. Brown, and D. L. Thiele. 2003. The role of TNF-TNFR-2 interactions in generation of CTL responses and clearance of hepatic adenovirus infection. J. Leukocyte Biol. 74:564.
13. Elkon, K. B., C. C. Liu, J. G. Gall, J. Trevejo, M. W. Marino, K. A. Abrahamsen, X. Song, J. L. Zhou, L. J. Old, R. G. Crystal, and E. Falck-Pedersen. 1997. Tumor necrosis factor-α plays a central role in immune-mediated clearance of adenoviral vectors. Proc. Natl. Acad. Sci. USA 94:9814.
14. Buzza, M. S., C. E. Hirst, C. H. Bird, P. Hosking, J. McKendrick, and P. I. Bird. 2001. The granzyme B inhibitor, PI-9, is present in endothelial and mesothelial cells, suggesting that it protects bystander cells during immune responses. Cell. Immunol. 210:21.
15. Bladergroen, B. A., C. J. Meijer, R. L. ten Berge, C. E. Hack, J. J. Muris, D. F. Dukers, A. Chott, Y. Kazama, J. J. Oudejans, O. van Berkum, and J. A. Kummer. 2002. Expression of the granzyme B inhibitor, protease inhibitor-9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system? Blood 99:232.
16. Bird, C. H., E. J. Blink, C. E. Hirst, M. S. Buzza, P. M. Steele, J. Sun, D. A. Jans, and P. I. Bird. 2001. Nucleocytoplasmic distribution of the ovalbumin serpin PI-9 requires a nonconventional nuclear import pathway and the export factor Crm1. Mol. Cell. Biol. 21:5396.
17. Medema, J. P., J. de Jong, L. T. Peltenburg, E. M. Verdegaal, A. Gorter, S. A. Bres, K. L. Franken, M. Hahne, J. P. Albar, C. J. Melief, and R. Offringa. 2001. Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors. Proc. Natl. Acad. Sci. USA 98:11515.
18. Bladergroen, B. A., M. C. Strik, N. Bovenschen, O. van Berkum, G. L. Scheffer, C. J. Meijer, C. E. Hack, and J. A. Kummer. 2001. The granzyme B inhibitor, protease inhibitor-9, is mainly expressed by dendritic cells and at immune-privileged sites. J. Immunol. 166:3218.
19. Sun, J., L. Ooms, C. H. Bird, V. R. Sutton, J. A. Trapani, and P. I. Bird. 1997. A new family of 10 murine ovalbumin serpins includes two homologs of proteinase inhibitor 8 and two homologs of the granzyme B inhibitor (proteinase inhibitor 9). J. Biol. Chem. 272:15434.
20. Kanamori, H., S. Krieg, C. Mao, V. A. Di Pippo, S. Wang, D. A. Zajchowski, and D. J. Shapiro. 2000. Proteinase inhibitor 9, an inhibitor of granzyme B-mediated apoptosis, is a primary estrogen-inducible gene in human liver cells. J. Biol. Chem. 275:5867.
21. Brown, G. R., D. L. Thiele, M. Silva, and B. Beutler. 1997. Adenoviral vectors given intravenously to immunocompromised mice yield stable transduction of the colonic epithelium. Gastroenterology 112:1586.
22. Nakabayashi, H., K. Taketa, K. Miyano, T. Yamane, and J. Sato. 1982. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res. 42:3858.
23. Wu, J. C., G. Merlino, and N. Fausto. 1994. Establishment and characterization of differentiated, nontransformed hepatocyte cell lines derived from mice transgenic for transforming growth factor α. Proc. Natl. Acad. Sci. USA 91:674.
24. Nguyen, K., and B. C. Miller. 2002. CD28 costimulation induces δ opioid receptor expression during anti-CD3 activation of T cells. J. Immunol. 168:4440.
25. + T cell cytotoxic effector function. J. Immunol. 158:5200.
26. Sprecher, C. A., K. A. Morgenstern, S. Mathewes, J. R. Dahlen, S. K. Schrader, D. C. Foster, and W. Kisiel. 1995. Molecular cloning, expression, and partial characterization of two novel members of the ovalbumin family of serine proteinase inhibitors. J. Biol. Chem. 270:29854.
27. Boehm, U., T. Klamp, M. Groot and J. C. Howard. 1997. Cellular responses to interferon-γ. Annu. Rev. Immunol. 15:749.
28. Guidotti, L. G., and F. V. Chisari. 2000. Cytokine-mediated control of viral infections. Virology 273:221.
29. Dahlen, J. R., D. C. Foster, and W. Kisiel. 1997. Expression, purification, and inhibitory properties of human proteinase inhibitor 8. Biochemistry 36:14874.
30. Bertoletti, A., and C. Ferrari. 2003. Kinetics of the immune response during HBV and HCV infection. Hepatology 38:4.
31. McClary, H., R. Koch, F. V. Chisari, and L. G. Guidotti. 2000. Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines. J. Virol. 74:2255.
32. Guidotti, L. G., T. Ishikawa, M. V. Hobbs, B. Matzke, R. Schreiber, and F. V. Chisari. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4:25.
33. Kagi, D., P. Seiler, J. Pavlovic, B. Ledermann, K. Burki, R. M. Zinkemagel, and H. Hengartner. 1995. The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur. J. Immunol. 25:3256.
34. Kannna-Thulasiraman, P., and Shapiro, D. J. 2002. Modulators of inflammation use nuclear factor-κB and activator protein-1 sites to induce the caspase-1 and granzyme B inhibitor, proteinase inhibitor 9. J. Biol. Chem. 277:41230.
35. Vermijlen, D., D. Luo, C. J. Froelich, J. P. Medema, J. A. Kummer, E. Willems, F. Braet, and E. Wisse. 2002. Hepatic natural killer cells exclusively kill splenic/blood natural killer-resistant tumor cells by the perforin/ granzyme pathway. J. Leukocyte Biol. 72:668.
36. Scott F. L., H. J. Eyre, L. Ooms, J. Sun, P. I. Bird, and G. R. Sutherland. 1997. Proteinase inhibitor 8 map position 18q21.3. Chromosome Res. 5:279.
37. Sun, J., R. Stephens, G. Mirza, H. Kanai, J. Ragoussis, and P. I. Bird. 1998. A serpin gene cluster on human chromosome 6p25 contains PI6, PI9, and ELANH2 which have a common structure almost identical to the 18q21 ovalbumin serpin genes. Cytogenet. Cell Genet. 82:273.
38. Hirst, C. E., M. S. Buzza, C. H. Bird, H. S. Warren, P. U. Cameron, M. Zhang, P. G. Ashton-Rickardt, and P. I. Bird. 2003. The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency. J. Immunol. 170:805.
39. Kaiserman, D., S. Knaggs, K. L. Scarff, A. Gillard, G. Mirza, M. Cadman, R. McKeone, P. Denny, S. Cooley, C. Benarafa, et al. 2002. Comparison of human chromosome 6p25 with mouse chromosome 13 reveals a greatly expanded ov-serpin gene repertoire in the mouse. Genomics 79:349.